Das Markus-Krankenhaus ist ein evangelisches Krankenhaus der Schwerpunktversorgung in Frankfurt am Main. Architekten waren Otto Bartning und die Ingenieure Otto Dörzbach und Wolf. Der Standort des Krankenhauses ist im Stadtteil Bockenheim, an der Grenze zum Stadtteil Ginnheim.

During the past decade, Agaplesion Markus Krankenhaus conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 12 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 9 clinical trials were completed. i.e. 47.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Agaplesion Markus Krankenhaus" #1 sponsor was "Celgene" with 6 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Galapagos NV" with 3 trials sponsored, "AGO Research GmbH" with 2 trials sponsored and "Alliance Foundation Trials, LLC." with 2 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Agaplesion Markus Krankenhaus" #1 collaborator was "Gilead Sciences" with 4 trials as a collaborator, "German Breast Group" with 3 trials as a collaborator, "Pfizer" with 3 trials as a collaborator, "Austrian Breast & Colorectal Cancer Study Group" with 2 trials as a collaborator and "NSABP Foundation Inc" with 2 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "Agaplesion Markus Krankenhaus" are "Breast Cancer" (10 trials), "Crohn Disease" (6 trials), "Ulcerative Colitis" (5 trials), "Crohn's Disease" (4 trials) and "Breast Neoplasms" (3 trials). Many other conditions were trialed in "Agaplesion Markus Krankenhaus" in a lesser frequency.

Most popular intervention types in "Agaplesion Markus Krankenhaus" are "Drug" (34 trials), "Device" (12 trials), "Other" (5 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Carboplatin" (4 trials), "Exemestane" (4 trials), "Filgotinib" (4 trials) and "Ozanimod" (3 trials). Other intervention names were less common.

The vast majority of trials in "Agaplesion Markus Krankenhaus" are 40 trials for "All" genders and 12 trials for "Female" genders.

Currently, there are NaN active trials in "Agaplesion Markus Krankenhaus". undefined are not yet recruiting, 13 are recruiting, 8 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 20 completed trials in Agaplesion Markus Krankenhaus, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Agaplesion Markus Krankenhaus, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 5 trials that are defined as “Not Applicable".

Agaplesion Markus Krankenhaus has several departments that took part in Clinical trials: "Markus Krankenhaus Klinik für Gynäkologie und Geburtshilfe" - 2 trials